Eradigm team

Manager

Ilaria Coppola

Focus Therapy Areas: Oncology, Haematology, Neuroimmunology, Cardiovascular

Specialist Expertise: Cell & Gene Therapy, Rare Diseases, Digital Health

Education: BSc Biotechnology with a Year in Research, Imperial College London (First Class); MPhil Bioscience Enterprise University of Cambridge

What is your focus at Eradigm?

My focus is delivering high impact strategic insights at brand-level through peri-launch and post-launch Competitive Intelligence work, which includes attendance to leading therapy area conferences. My primary objective is providing value to the client with a meaningful so what? to ensure our contribution truly serves to identify future directions and tangible next steps.

Who do you work with?

My clients mainly include global CI managers, global and affiliate brand teams as well as senior strategic leaders across the top 15 biopharmaceuticals companies. On several occasions, my work has also exposed me to senior executive members from those organisations.

What is your specialist expertise, and what types of projects do you work on?

During my time at Eradigm, I have specialised in understanding the scientific and commercial value of cell & gene therapy (autologous, allogeneic), digital healthcare (digital therapeutics, screening algorithms) and rare neuroimmunological diseases. Within these fields, I have worked in CI monitoring projects, global technology landscaping and strategic workshop facilitation.

What did you do before Eradigm?

Before joining Eradigm, I interned in the Business Development Operations division at AstraZeneca, where I researched the regulatory and pricing interdependencies between European and International markets. 

What are your passions outside of work?

I am deeply curious about pretty much everything that happens around me, be it international politics, pop Instagram culture or a new restaurant that just opened down the road. However, my favourite ways of tetrising my free time include urban exploration, dinner hosting, swimming and 70s Italian thriller movies.

Manager

Antoine Coum

Focus Therapy Areas: Oncology, Neuroscience, Cardiovascular, Infectious Diseases

Specialist Expertise: Patient Services, Competitive Benchmarking, Market Access

Education: MSc Biochemical Engineering Ecole Nationale Supérieure de Chimie de Montpellier, MSc Cancer Biology Université de Montpellier II, PhD Developmental Neurobiology King’s College London

What is your focus at Eradigm?

I provide valuable, strategic insights through the synthesis of information from highly relevant secondary research resources and conduct of interviews with first-class leading subject-matter experts, and aim to garner and contribute pioneering recommendations impactful for clients and patients alike.  

Who do you work with?

I partner with a range of stakeholders, including commercial and global brand teams, from both Big Pharma and mid-sized companies. I actively look to work alongside innovative oncology and healthcare technology organisations to promote a patient-centric approach to health and care globally.

What is your specialist expertise, and what types of projects do you work on?

I have a holistic understanding of the healthcare paradigm, from pre-clinical innovation to product life cycle management, as well as a swiss-army knife knowledge of several therapeutic areas. My rapidly growing project experience includes Global Competitive Intelligence monitoring of infectious diseases, strategic assessment of innovative patient services in rare diseases, and assessment of payer value perception of patient services in Haematology Market Access .

What did you do before Eradigm?

Before joining Eradigm, I developed BD and deep industry expertise while working at the Gerson Lehrman Group, partnering with senior executives of pharmaceutical and healthcare technology companies to engage with subject-matter experts.

What are your passions outside of work?

My main interest outside of work revolves around fitness and wellbeing through the practice of basketball and swimming, as well as any physical activity accessible. I balance over-exercising by immersing myself in physical books, with a soft spot for poetry.

Manager

David McBay

Focus Therapy Areas: Oncology, Haematology, Immunology

Specialist Expertise: Cell & Gene Therapies, Digital Therapeutics, Value-Based Healthcare

Education: PhD Institute of Cancer Research; MSci Genetics University College London

What is your focus at Eradigm?

My focus is on delivering the highest quality of personalised, impactful research and insights that align with our client’s priorities to drive significant impact in Competitive Intelligence and Market Access. I work more often in clinically-focussed Competitive Intelligence, particularly to inform cell & gene therapy strategy.

Who do you work with?

I work with global Market Access, Competitive & Market Intelligence & Brand team leads across top 10 biopharma companies, in addition to cell and gene therapy focussed biotech. I have also recently worked with senior biopharma leadership on broader corporate strategy.

What is your specialist expertise, and what types of projects do you work on?

Global CI, particularly in the US for oncology and immunology; Global Market Access for cell and gene therapies; ‘beyond the pill’ commercial strategy and digital therapeutic corporate strategy are personal areas of expertise.

What did you do before Eradigm?

Before joining Eradigm, I undertook a PhD in DNA Damage Repair & Radiotherapy at the ICR, a particularly unique university given its biopharma industry partnerships and translational focus. I complimented my scientific studies by gaining commercial exposure through direct involvement on the ICR’s Board of Trustees. 

What are your passions outside of work?

Outside of work, I’m passionate about a five-a-side kayaking team sport called ‘Canoe Polo’, competing at an international level, including the CPSL Super League. I also have a love for conservation and travelling that I combine through amateur wildlife photography.

Senior Consultant

Flavia Fioretti

Focus Therapy Areas: Oncology, Immunology/Rheumatology, Vaccines, Rare Diseases

Specialist Expertise: Competitor strategy, lifecycle management, clinical trial design, manufacturing and supply chain analysis, Cell & Gene Therapy, ADC, Biosimilars

Education: MSc Molecular Biology, University “Federico II” of Naples; MRes in Cancer Biology, Imperial College London; Ph.D. in Oncology Drug Development, Imperial College London

What is your focus at Eradigm?

At Eradigm, I bring deep scientific expertise, and clinical and commercial insights to answer our clients’ critical questions both on Strategy and Global Competitive Intelligence projects, always striving for a meaningful and collaborative approach in every engagement.

Who do you work with?

I work with global commercial and intelligence leads from Top 10 Pharma companies and small to mid-sized biotechs, bridging the gap between different teams and supporting decision-making at a product, franchise, and corporate level.

What is your specialist expertise, and what types of projects do you work on?

I have deep expertise in oncology (solid and heme), precision medicine, and next-generation diagnostics. However, I have worked on a broad range of engagements across a range of therapy areas and geographies, including product lifecycle management and long-term global CI monitoring.

What did you do before Eradigm?

Before joining Eradigm, I spent 4 years at another consulting firm in the UK leading multiple competitive strategy engagements supporting the development and commercialisation of several assets. Before consulting, I worked as a clinical project manager in early-phase clinical trials where I acquired in-depth expertise on clinical trial design and the regulatory landscape for drug approval.

What are your passions outside of work?

Outside of work, I rest and relax by practicing yoga and spinning, buying plants, immersing myself in a good book, visiting museums and exhibitions, or going on long car drives to sing songs from the noughties very loudly.

Senior Consultant

Nathanael Green

Focus Therapy Areas: Oncology, Haematology, Immunology

Specialist Expertise: Cell & Gene Therapy, Pricing Strategy, Market Access and Personalised Medicine

Education: BSc Biochemistry, Cardiff University (Upper Second Class); MSc Drug Development Sciences, King’s College London (Distinction)

What is your focus at Eradigm?

To drive forward my passion for deciphering the true value of innovative healthcare products to provide strategic insights and solutions for impactful Market Access launch strategies. Working across a wide range of asset-level and Corporate Strategy projects, and Global Competitive Intelligence Monitoring, my aim is to deliver top-tier impactful recommendations and strategies to drive success for our clients.

Who do you work with?

I predominately work with global franchise teams, Market Access and commercial strategy leaders and senior leadership teams of top 15 biopharmaceutical and biotech companies.

What is your specialist expertise, and what types of projects do you work on?

My expertise lies within Cell & Gene Therapies and Market Access Excellence. My project portfolio has focused on several key areas, including cell & gene therapies (launch excellence, manufacturing and commercial strategy), pricing strategies (pre-launch and LOE), CI monitoring and Market Access Strategy & Access.

What did you do before Eradigm?

Before joining Eradigm, I gained Market Access experience as part of the Life Sciences Strategy & Access team at BearingPoint, where I contributed to several projects focusing on topics ranging from oncology to AI in healthcare. Prior to this, I presented my dissertation research on the Pharmacoeconomics and Market Access of Orphan Drugs as a finalist at the ISPOR 2019 conference.

What are your passions outside of work?

Outside of work, I enjoy long distance running, having completed numerous half and full marathons, and am a keen skier. I am also a passionate cook and love a wide range of music.

Senior Consultant

Brynna Hoggard

Brynna joined Eradigm in July 2021 as an Associate Consultant, bringing extensive experience in biomedical research and a passion for global healthcare.

She holds a PhD in Cancer Biology from Barts Cancer Institute in London, part of Barts and the London School of Medicine and Dentistry. Her research was funded by the Biotechnology and Biological Sciences Research Council and focused on using technology to answer biological questions. There she was part of a multidisciplinary team of biologists and engineers, working to characterise and target a newly identified lung cancer driver mutation, and identify novel therapeutic strategies to treat it.

After completing her PhD, Brynna was awarded a grant to continue her research at Barts Cancer Institute as a postdoctoral researcher, and begin translating her research in the clinical sphere.

Prior to her academic studies, Brynna also worked in global health, where she developed tailored solutions to meet the needs of rural communities in Madagascar. There she led an initiative to improve public and environmental health through sustainable economic growth.

Outside of work, Brynna loves trying new and delicious food, as long as she doesn’t have to do the cooking. She is also an avid reader, loves taking on new knitting projects, and is learning to play the piano.

Senior Consultant

Anselm Lee

Focus Therapy Areas:

Immunology, Oncology, Rare diseases, Neurology

Specialist Expertise:

Commercial Strategy, Market Access Strategy, Lifecycle Management, Commercial Opportunity Assessments/Due Diligence, Workshop Facilitation

Education:

MSc Biochemical Engineering, University College London

What is your focus at Eradigm?

My aim at Eradigm is to aid clients in the development of strategic recommendations for launch excellence, market access, as well as various other engagement types within the commercial strategy space.

Who do you work with?

I typically work with therapeutic/brand-specific global/local teams of top 20 pharmaceutical companies.

What is your specialist expertise, and what types of projects do you work on?

I have extensive experience across various types of commercial & market access strategy engagements, from due diligences to brand strategy engagements.

Key project areas include: commercial opportunity assessments, brand/portfolio strategy, analogue analysis, patient/product pathway analysis, market access strategy.

What did you do before Eradigm?

Prior to Eradigm, I spent ~5 years working at various LS-oriented strategy firms focusing on product commercialisation, market access, digital transformation, and launch excellence.

What are your passions outside of work?

Besides work, I enjoy keeping physically fit through a variety of sports including bouldering, Muay Thai, and general physical exercise, as well as less-physical activities such as playing the violin and tending to my orchids.

Senior Associate Consultant

Sneha Chatterjee

Sneha joined Eradigm in April 2022 as an Associate Consultant, bringing to the team her experience in infectious diseases research and a strive for contributing to global healthcare enhancement.

Sneha worked in consulting projects spanning therapeutic areas such as oncology, infectious diseases, haematology and rare diseases, and devices. She was involved in conducting competitive intelligence for multiple projects delivered on market assessment, data analytics, KOL profiling and social media analytics geographies including US, EU, LATAM and APAC markets. She was responsible for project management and driving multiple strategic intelligence engagements for year-long tracker projects to help clients understand and strategize their competition. She has also gained profound experience in collecting comprehensive market, competitor and stakeholder evidence through desk-based interviewing and elicitation; conducting research and analysing industry trends and data, create competitive landscape to understand the healthcare scenario, and comprehend reimbursement policies in global pharmaceutical market.

By qualification, Sneha is a medical microbiologist and obtained her PhD in infectious diseases with her research in the in overlapping fields of immunology and host-pathogen interaction, from the Medical University of Innsbruck, Austria. Her thesis decoded the role of Shiga toxin produced by Enterohemorrhagic E. coli (EHEC) in Haemolytic Uremic Syndrome (HUS). Prior to that, she secured her masters in Applied Microbiology from the VIT University, India, and bachelors in Microbiology (Honours) from the University of Delhi, India.

Outside of work, Sneha loves to travel and enjoys being acquainted with new cultures and trends. She loves to sing and has also lent her voice to a few short films as a playback singer. She is also trained in Indian dance forms, which she feels keeps her connected to her roots. Sneha loves to try out new cuisines and try her hands at cooking every once in a while.

Sneha believes in the idea of translational research with direct bench-to-bedside significance, and with her cumulative experience, would like to contribute to create a positive impact in the global healthcare space.

Consultant

YanWen Chong

YanWen brings with her a breadth of healthcare, research, and management consulting experience as she joins Eradigm in April 2022. Her previous professional experience includes strategy and operations consulting in PricewaterhouseCoopers as well as drug re-purposing research in a joint Masters’ project between UCL and Hanyang University of South Korea. Her previous consulting experience includes delivering and supporting work in:

Pharmaceutical & Life Sciences: Cost-to-serve, customer service models, market access, regulatory and reimbursement, digital operations, and commercialisation strategies with global PharmaCos and Medtech clients.

Healthcare: Strategy development, strategic option appraisals, benefits costing, operating model design, and system level sustainability plan development with NHS Trusts and Integrated Care Boards.

In building a cross-functional, broad therapeutic portfolio and having a strong person-centric health and care foundation, YanWen hopes to deliver meaningful strategic insights and recommendations that will make a difference.

Outside of work, YanWen loves being active and exploring the city by foot, being a wannabe foodie, and planning her next adventure. Her curiosity in all things DIY and love for socialising means lots of crafty projects (they make for cozy events – pumpkin carving? wreath making? #yes). And of course, she enjoys a good pint or a cheeky cocktail while engaging in conversations about the meaning of life!

Consultant

Jeanne-Claire Vincent

Focus Therapy Areas: Oncology (Solid Tumors & Hematology), Rare Disease, Cardiovascular

Specialist Expertise: Pricing and Market Access Strategy, Landscape Assessments, Market Insights

Education: BEng Mechanical Engineering, McGill University; MScEng Biomedical Engineering, Imperial College London

What is your focus at Eradigm?

At Eradigm, I bring a strong analytical background and understanding of global strategy, access, and pricing dynamics. My focus delivering targeted and impactful insights and recommendations to clients through high quality research and a collaborative engagement approach

Who do you work with?

I typically collaborate with global commercial and access teams, from both top 10-pharma and small to mid-size biotech companies.

What is your specialist expertise, and what types of projects do you work on?

My expertise lies in achieving developing strategic solutions to address business needs across broad therapeutic areas and geographical regions. I work across different project types delivering impactful market insights, commercial strategy recommendations, and understanding various pricing and reimbursement challenges in key geographies including the EU and Japan. Key capabilities include global primary research experience with payers and stakeholders, as well as secondaryresearch based landscape mapping in oncology, giving strategic support to clients across the product development lifecycle

What did you do before Eradigm?

Prior to Eradigm, I completed my MScEng degree in Biomedical Engineering completing a year-long research project working with a multidisciplinary team of doctors and engineers to build computational models that simulate and predict the development of congenital heart diseases in fetuses

What are your passions outside of work?

Outside of studies and work, I participated in several medical mission trips to rural and underserved communities in Haiti, Jamaica, India, and Brazil; experiences which have given me the motivation to make an impact on society through the biopharma industry. In my spare time, I love to travel, read and watch old movies

Consultant

Barney Poznansky

Barney joined Eradigm in January 2022 as an Associate Consultant, bringing an experience in bioscience research and a passion for improving global healthcare.

He holds a PhD in Interdisciplinary Bioscience from the University of Oxford, which formed part of a Doctoral Training Programme funded by the Biotechnology and Biological Sciences Research Council. Barney’s work focused on combining biocatalysts with continuous flow technology to improve the sustainable synthesis of pharmaceutical compounds. He was part of a team of chemists, biologists and engineers who worked to develop this biotechnology and successfully spin-out a company. In recognition of his work on this project, Barney was awarded a commendation in Enterprise and Innovation at the University of Oxford Bioscience Impact Awards.

As part of his PhD, Barney undertook a work placement at a large generics company. As part of the team, Barney applied the processes that he had developed in the academic laboratory to industrially relevant chemical transformations.  

Barney completed his formative academic studies at the University of Warwick, graduating with an MChem in Chemistry with Professional Experience. His dissertation focused on performing enantioselective synthesis using novel organocatalysts. During his third year of study, Barney undertook a four-month placement at Monash University, Australia, which ignited his passion for academic research. 

Outside of his work, Barney is a keen sportsman, who has played football at university level. He continues to enjoy many other sports, including cricket, golf, and squash, and finds pleasure in cooking, having a particular love for Indian and Italian cuisine. An inherited passion for music took hold during his younger years, growing up in Cornwall, at which time he travelled with local orchestras to perform in locations as far afield as San Francisco.

Consultant

Sean Abbott-Imboden

Sean joined Eradigm as an Associate Consultant in August 2022, bringing to the team his prior experience in healthcare consultancy, medical communications and data management.

Sean previously worked at a boutique life sciences consulting firm, where his role centred on conducting primary and secondary research to identify key market events and trends to support pharmaceutical companies’ strategy. Sean has worked with a plethora of pharmaceutical companies across a range of therapeutic area specific projects and cross-portfolio workstreams. Prior to this, Sean worked in Data Management for a top-10 clinical research organisation where he was responsible for reconciling and analysing clinical trial data, maintaining study documentation, and performing quality control audits of clinical trial databases.

Sean holds a BSc in Biomedical Sciences from the University of Warwick which provided him with a platform to pursue his MSc in Cancer Biology at University College London (UCL). His MSc (Distinction) consolidated his skills in critically evaluating primary and secondary scientific literature, experimental planning and interpretation of results. Diverging away from his oncology background to supplement his knowledge and support broader research efforts, his MSc dissertation focused on developing a computational in-silico model to identify drug combinations to fight COVID-19. His work contributed to a scientific publication in Nature Partner Journals – Digital Medicine.  

Sean’s academic and professional experiences have provided him with a deep understanding of the commercial and therapeutic landscape across oncology, neurology and COVID-19 as well as continually emerging fields such as digital healthcare.

Outside of work, Sean is a huge sports enthusiast. He is particularly keen on playing football, running, going to the gym and skiing. He also enjoys travelling and spending time with friends and family.

Consultant

Oliver Odell

Oliver holds a PhD in Nutrition and Human Metabolism from the University of Birmingham, which was part of a Doctoral Training Programme funded by the Biotechnology and Biological Sciences Research Council. Oliver’s work focused on dairy nutrition, specifically trying to understand the metabolism of the milk sugar lactose in humans, to try to identify new applications for this low value, side stream product of the dairy industry. He has run human volunteer studies, in university laboratory and hospital settings across the country. He is interested in the intersection of nutrition and other modifiable lifestyle factors and healthcare, as well as life sciences and health more broadly.

Oliver also spent time working with the industrial partner of his PhD, a major European dairy ingredients company. He ran a market research project into consumer habits to identify gaps in product offerings and nominate new ingredients and products for development. This built on his previous experience in market research, throughout his undergraduate degree at the University of Exeter. Throughout his PhD, Oliver taught undergraduates extensively, from lecturing to running laboratory sessions. He particularly enjoyed the process of breaking down complex topics and explaining them to students. He is also an Associate Fellow of the Higher Education Academy.

Oliver is a passionate scuba diver, having recently completed his rescue diver qualification, he has dived extensively in Europe, Asia and Africa. Oliver is also a competitive powerlifter in his free time though has a keen interest in other strength sports. Throughout 2021 he volunteered with St John Ambulance to assist with the vaccine rollout, administering vaccines and helping to organise the day to day running vaccine centres.

Consultant

Liam Maddison

As Liam joins Eradigm in July 2022 as an Associate Consultant, he brings a wealth of early-stage therapeutic discovery expertise following the completion of his industry-partnered PhD programme. He has a keen interest in the application of disruptive technologies within the healthcare landscape and a desire to work with key stakeholders to revolutionise current treatment paradigms.

Undertaking his PhD research at The University of Leeds, Liam spearheaded an early-stage drug discovery campaign against a prominent epitranscriptomic regulator, with the promise to meet unmet needs in oncology and virology. The project identified a collection of novel hits against the target, culminating in the development of a potent lead compound that will be the subject of further optimisation, laying the groundwork for therapeutic development. Throughout this project, Liam managed a multi-centre collaboration and worked closely with scientists and leadership at his pharmaceutical partner company.

During his PhD studies, Liam nurtured a growing interest in the commercial aspects of the Life Sciences sector, competing in national entrepreneurship competitions and securing freelance consulting work to enhance his skillset. Here, he worked alongside top 20 pharma clients to hone his CI skills, conducting market research and conference monitoring across the cell therapy and HIV landscapes.

Prior to this, Liam completed an integrated master’s degree in Medicinal chemistry at the University of Leeds, where he discovered an interest in the pharmaceutical industry and developed expertise in small molecule drug development.

In his free time, Liam enjoys getting outdoors as much as possible, whether that be backpacking, hiking or trail running. When not out in nature, you will most likely find him anxiously watching Newcastle United, listening to his vinyl record collection, or kicking back with a good book.

Consultant

Nadeen Solaiman

Nadeen joined Eradigm in April 2022 as an Associate Consultant, bringing to the team her extensive experience in genetic engineering and cancer research, and everlasting passion for the Life Sciences industry.

Nadeen holds a PhD in Molecular Biology & Biochemistry from the University of Westminster, where her work focused on the molecular characterisation a novel cancer driver gene in replication stress-induced genomic instability using CRISPR/Cas-based human cellular models, in collaboration with the Francis Crick Institute and the University of Zurich. During the pursuit of her doctorate, Nadeen was awarded research grants to support the clinical translation of genetically-engineered human cellular models to commercial products, in collaboration with renowned Life Science industries. Nadeen was also heavily involved in the co-design and mentorship of IBMS-accredited CRISPR/Cas-based workshops where she was consulted for her technical expertise on the use and applications of the cutting-edge technology.

Alongside her PhD studies, Nadeen acquired a professional development qualification in learning and teaching within the Higher Education Academy, U.K., and held a Visiting Lectureship position in Life Sciences at the University of Westminster for over three years. She also has experience in working as a Molecular Biologist at Health Services Laboratories (HSL) where she acquired extensive knowledge on the evolving clinical diagnostic landscape.

Outside of work, Nadeen is a curious soul who enjoys meeting new people and visiting new places. In her spare time, Nadeen enjoys salsa dancing as well as fitness through the practice of kickboxing, running and Pilates. She also enjoys reading on Science-related subjects and self-development, and whenever she gets the opportunity, she loves to travel and explore new cultures.  

Senior Associate Consultant

Paula Wegbrans Giro

Paula joined Eradigm in May 2022 as an Associate Consultant. With a keen interest in personalised medicine and novel therapies, Paula brings her experience in biomedical research to the team.

Paula holds an MSc in Engineering for Biomedicine from Imperial College London, where she researched new materials approaches for the detection and treatment of cancer. Prior to that, Paula completed her BSc in Human Biology from Pompeu Fabra University in Spain, where she took a multidisciplinary approach to learn about biomedical sciences and did her bachelor’s thesis on secretion pathways altered by colon cancer. During her BSc, Paula did an exchange programme at the Amsterdam University College in The Netherlands where she took global healthcare courses and developed her language skills.

Alongside her education, Paula spent time doing internships at the University of California San Diego, in the US, and at Sant Pau Hospital, in Spain, where she explored clinical and genetic approaches to diseases of the airways. These experiences in different cultures grew her ambition to use her life sciences knowledge for application approaches in an industry environment and led Paula to work on innovation strategies in between her studies.

Paula also believes in bringing scientific knowledge and education closer to those outside the science and medical communities and has worked and volunteered in Medical Information and Tutoring projects to increase accessibility in these areas.

Outside of work, Paula enjoys travelling, cooking, and music. She has a keen interest in combining these three hobbies and finding new ways of sharing them with other people. 

Senior Associate Consultant

Zain Aziz

Zain joined Eradigm in May 2022 as an Associate Consultant bringing to the team his curiosity for the life sciences and passion for global healthcare.

Prior to joining Eradigm, Zain has worked in consulting projects with different healthcare providers across Europe aiding in their digital transformation process and the implementation of electronic patient healthcare record systems. His focus was mainly within clinical research organisation, and he was heavily involved with advising clients as to how to identify potential opportunities to increase recruitment onto clinical studies, as well as increasing patient study visibility for trust members, with the end goal to provide better overall care for patients being treated.

Zain holds a BSc and PhD in Biomedical Sciences and Biotechnology, respectively from the University of Westminster. His research was focused on the development of novel fermentation strategies to increase the production of bioplastics through the manipulation bacterial communication circuits. During his PhD, Zain was also able to acquire a professional development qualification in learning and teaching within the
Higher Education Academy, U.K.

Outside of work, Zain is an avid hiker and frequent gym-goer who loves to travel and visit new places. In his free time, he enjoys exploring London’s live music offerings and carrying out DIY projects.

Senior Associate Consultant

Kamaal Lynch-Samms

Kamaal Joins Eradigm as an associate consultant bringing experience in psychiatric disorder treatment research and a desire to improve drug discovery pipelines.

He holds a BSc in Pharmacology from UCL where his passion for the translation of preclinical research to life-changing clinical therapies was initiated. During his degree, he conducted a research project where he screened BK channel activating drugs on the voltage dependence of BK channels using patch-clamp techniques. He was part of a team of pharmacologists and bioscientists investigating these BK channel properties for insights into respiratory diseases and potential treatments.

During his studies, Kamaal worked as a Covid-19 testing assistant in the UCL testing site where he gained a unique first-hand perspective of the impact of the global pandemic.

In between his studies, Kamaal solely produced and released a report on the most novel antidepressant and anxiolytic drugs in phase II clinical trials or later for the mental health charity Overcome, as an intern. This report was a part of the charity’s initiatives focused on providing accessible and free solutions globally for psychiatric disorders. As a business development intern for FlowCell Kamaal got to grips with the needs of end-users in the neuroscience field by liaising with potential clients to build customer profiles.

Outside of work, Kamaal is a keen fitness enthusiast playing American football competitively and being an avid gym-goer. He has a passion for Sci-Fi/fantasy books and films with his current favourite being the Dune book series by Frank Herbert due to its expansive story and philosophical overtones.

Senior Associate Consultant

Joshua Wyatt

Joshua joined Eradigm in September 2022 as an Associate Consultant, bringing his relevant academic and professional experience alongside.

Joshua holds an Honours BSc from the University of Toronto in Canada, from a joint program with the School of the Environment and the Department of Pharmacology and Toxicology within the Faculty of Medicine. Here, Joshua discovered his interest in chemical pollutants, antibiotic resistance, and climate change. In the midst of his undergrad, Joshua participated on an academic exchange to the University of Amsterdam, Netherlands, where he gained a global view on the pharmaceutical industry. Further his studies, Joshua went forth to complete a Masters degree in Drug Discovery and Pharma Management at the UCL School of Pharmacy in London, England. In his dissertation, Joshua studied the recent trends in Alzheimer’s disease drug development and clinical trial research, and discovered important findings in the commercial operations of the neurodegenerative disease space.

Alongside his undergraduate studies, Joshua worked at a small toxicological research organization, contributing to reports and datasets on various chemicals around the globe, and how they bioaccumulate within different species and their food systems. Alongside his graduate dissertation, Joshua worked an internship with Clarivate Analytics, where he learned a vast amount about life science consulting, and the various projects, deliverables, and resources many different companies require to advance their pipeline and revenue.

Outside of academia and work, Joshua coached local swim teams and helped organize community events around Toronto, making great friends and memories along the way. In his spare time, Joshua loves to cycle around the countryside, play basketball with friends, and practice his musical instruments.

Senior Associate Consultant

Shreya Murali

Shreya joined Eradigm in April 2021 as an associate consultant. With a keen interest in novel therapeutic strategies, Shreya brings her experience in biomedical research and knowledge of the pharmaceutical industry to the team.

Shreya achieved her Master’s in Novel Therapies- Genes, Drugs and Stem Cells at Imperial College London where she took a multidisciplinary approach to understanding gene therapies, regenerative medicine, and the drug development process. For her master’s thesis, she worked on the optimization of synthetic mRNA for therapeutic use in airway epithelial cells. Prior to this, she completed her Bachelor’s degree in Genetics from the University of Sussex where she carried out research investigating the relationship between the structure and stability of DNA replication checkpoint proteins.

Alongside her academics, Shreya worked on an investment management start-up specializing in digital assets. This venture stimulated her ambition to apply her experience in life sciences in a more strategic business environment. She is also a huge believer in increasing the accessibility of education and has spent a year as a volunteer teacher, tutoring underprivileged kids in shelter homes in mathematics and science.

In her free time, Shreya enjoys exploring new restaurants, going to the cinema, and hiking. She summited Mt Kilimanjaro in 2018 to fundraise for clean water and sanitation and aims to summit Mt Everest by 2026.

Senior Associate Consultant

Isaac Bryan

Isaac joined Eradigm as an Associate Consultant in September 2022, bringing with him a breadth of experience working in pharmaceutical market research. 

In his previous role, Isaac focused on conducting primary and secondary quantitative research, in order to provide actionable insights that would answer clients research needs and objectives. Isaac has experience utilising a wide array of complex research methodologies and working with some of the largest pharmaceutical companies around the world. It was during this time that he developed a real passion for global healthcare.

Isaac holds a Bsc in Psychology from the University of Manchester through which helped him gain extensive knowledge in areas such as behavioural psychology, cognitive neuroscience, quantitative research methodologies, and statistics and data analysis. For his dissertation he carried out his own research study, investigating the effects of loss aversion on visual extrapolation under risk. 

Outside of work, Isaac is a big sports enthusiast with a particular passion for football, going to the gym and skiing. However Isaac is also big into his travel, music and cooking.